Trevor Hallam

Trevor Hallam

Net worth: 567 079 $ as of 2024-03-30

65 year
Health Technology
Consumer Services
Commercial Services

Profile

Trevor Hallam worked as Vice President-Biologics at AstraZeneca PLC, Head-Inflammation Research at Roche Pharmaceuticals, Inc., Head-Respiratory & Inflammatory Biology at Rhone Poulenc Rorer, Research Manager at Glaxo Group Research Ltd., and Scientist at Smith Kline & French BV.
He also served as Executive Vice President-Research & Development at Palatin Technologies, Inc. from 2005 to 2010 and as Chief Scientific Officer & President-Research at Sutro Biopharma, Inc. from 2021 to 2023.
Dr. Hallam earned a doctorate from the University of Cambridge and King's College London, and an undergraduate degree from the University of Leeds.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-13 100,368 ( 0.16% ) 567 079 $ 2024-03-30

Former positions of Trevor Hallam

CompaniesPositionEnd
SUTRO BIOPHARMA, INC. Chief Tech/Sci/R&D Officer 2023-05-30
PALATIN TECHNOLOGIES, INC. Chief Tech/Sci/R&D Officer 2010-12-30
Corporate Officer/Principal -
Corporate Officer/Principal -
Glaxo Group Research Ltd. Corporate Officer/Principal -
See the detail of Trevor Hallam's experience

Training of Trevor Hallam

University of Cambridge Doctorate Degree
University of Leeds Undergraduate Degree
King's College London Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Trevor Hallam's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ASTRAZENECA PLC

Health Technology

PALATIN TECHNOLOGIES, INC.

Health Technology

SUTRO BIOPHARMA, INC.

Health Technology

Private companies4

Commercial Services

Process Industries

Glaxo Group Research Ltd.

Smith Kline & French BV

See company connections